Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 38,230	$ 38,241
Restricted cash	227,568	256,237
Derivatives	4,253	17,958
Prepaid expenses and other current assets	1,322	2,089
Total current assets	271,373	314,525
Property, plant and equipment, net	4,329,376	2,437,733
Operating lease right-of-use assets	167,168	170,827
Deferred financing fees	340,488	389,695
Other non-current assets	15,557	11,021
Total assets	5,123,962	3,323,801
Current liabilities:
Accounts payable	224,358	243,129
Accrued and other current liabilities	331,029	306,115
Operating leases	2,887	3,143
Total current liabilities	558,274	552,387
Debt, net	3,315,150	1,816,301
Operating leases	144,588	145,962
Derivatives	60,219	66,899
Other non-current liabilities	0	1,818
Total liabilities	4,078,231	2,583,367
Commitments and contingencies (Note 11)
Stockholders’ equity
Common stock, $0.0001 par value, 480.0 million authorized: 260.1 million and 256.5 million outstanding, respectively	26	26
Treasury stock: 3.1 million shares and 2.2 million respectively, at cost	(20,791)	(14,214)
Preferred stock, $0.0001 par value, 0.5 million authorized: none outstanding	0	0
Additional paid-in-capital	1,209,753	693,883
Accumulated deficit	(519,201)	(391,772)
Total stockholders’ equity	669,787	287,923
Non-controlling interest	375,944	452,511
Total equity	1,045,731	740,434
Total liabilities and equity	$ 5,123,962	$ 3,323,801